Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: J Herb Med. 2021 Jan 8;26:100427. doi: 10.1016/j.hermed.2021.100427

Table A.3.

Results of Liver Function Tests (n = 26).

Parameter (normal reference range) Before hypoxoside tablets, mean ± sd [95% CI] After hypoxoside tablets, mean ± sd [95% CI] p value*
AST (<42 U/ L) 27.8 ± 5.8 [25.3 – 30.2] 29.0 ± 7.8 [25.7 – 32.2] 0.84
ALT (< 42 U/ L) 26.9 ± 7.6 [23.8 – 30.0] 23.9 ± 13.1 [18.6 – 29.2] 0.15
ALP (20 – 130 U/L) 109.8 ± 52.4 [88.6 – 131.0] 84.8 ± 35.9 [70.3 – 99.3] 0.09
Total protein (60 – 81 U/ L) 74.5 ± 7.6 [71.5 – 77.6] 77.6 ± 6.0 [75.2 – 80.0] 0.04
Albumin (35 – 50 g/ L) 42.9 ± 5.7 [40.5 – 45.2] 44.3 ± 6.8 [41.5 – 47.0] 0.40
GGT (15 – 85 U/ L) 39.3 ± 17.5 [32.2 – 46.3] 40.9 ± 14.3 [35.1 – 46.6] 0.62
Total bilirubin (3 – 21 μmol/ L) 6.5 ± 3.6 [5.0 – 8.0] 6.8 ± 2.5 [5.8 – 7.8] 0.75
Direct (conjugated) bilirubin (2.1 – 5.1 μmol/ L) 3.2 ± 1.1 [2.7 – 3.6] 3.2± 1.1 [2.7 – 3.6] 0.96

Outliers at baseline excluded from analysis (n=2)

*

p-value obtained from paired t-test

sd – standard deviation

CI – confidence interval